Category Health & pharma

Denmark cuts growth forecast as Novo slowdown sparks reliance debate
Denmark’s government has lowered its 2025 economic growth forecast to 1.4% from a previous projection of 3%, citing weaker prospects for pharmaceut...
Aug, 29, 2025
4 min read
by Invezz

Eli Lilly joins forces with China tech giant to expand obesity drug market
Eli Lilly has partnered with a leading Chinese tech company, JD Health to fast-track its presence in China’s rapidly expanding obesity drug market,...
Aug, 29, 2025
2 min read
by Invezz

Outlook Therapeutics plunges more than 52% after FDA rejects wet AMD drug
Shares of Outlook Therapeutics fell sharply on Thursday after the US Food and Drug Administration (FDA) rejected the company’s application for its ...
Aug, 28, 2025
3 min read
by Invezz

Eli Lilly stock jumps in pre-market trading: what’s driving the surge?
Eli Lilly & Co’s experimental obesity pill orforglipron helped patients lose 9.6% of their body weight in a late-stage trial, moving the drug a ste...
Aug, 26, 2025
2 min read
by Invezz